An error occurred retrieving publication content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
1 Centre for Academic Child Health, University of Bristol, Bristol Medical School, Bristol, UK
2 Bristol Trials Centre (Bristol Randomised Trials Collaboration), Bristol Medical School, Department of Population Health Sciences, University of Bristol, Bristol, UK
3 Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Primary Care Building, Oxford, UK
4 Centre for Academic Primary Care, Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, UK
5 School for Policy Studies, University of Bristol, Bristol, UK
6 Primary Care and Population Sciences, University of Southampton, Aldermoor Health Centre, Southampton, UK
7 NHS England and NHS Improvement, South West, UK
8 School of Population Health and Environmental Sciences, King’s College London, London, UK
* Corresponding author Email: p.s.blair@bristol.ac.uk
Disclosure of interests
Full disclosure of interests: Completed ICMJE forms for all authors, including all related interests, are available in the toolkit on the NIHR Journals Library report publication page at https://doi.org/10.3310/UCTH3411.
Primary conflicts of interest: Peter Blair, Padraig Dixon, Jenny Ingram, Jeremy Horwood, Patricia Lucas, Christie Cabral, Nick Francis, Elizabeth Beech, Martin Gulliford, Sam Creavin, Janet Lane and Alistair Hay were all co-investigators of the CHICO trial, so they were in receipt of NIHR funding. Alistair Hay is a member of the NIHR EME Committee and, at the time of funding, was a member of the NIHRHTA Committee. Jane Lane is a member of a clinical trials unit in receipt of NIHR support funding. Sam Creavin’s institution receives payments for the EMIS® development time, Wellcome trust doctoral fellowship and their NIHR ACL. Sam Creavin has a membership with HTA PCCPI Panel –May 2018, HTA Prioritisation Committee A (out of hospital) – May 2018–March 2022 and NICE diagnostic advisory committee – October 2022 to the present. Martin Gulliford was a member of the HSDR Funding Committee – May 2016–May 2019.
Trial registration: This trial is registered as ISRCTN11405239 (date assigned 20 April 2018) at www.controlled-trials.com (accessed 5 September 2022). Version 4.0 of the protocol is available at: https://www.journalslibrary.nihr.ac.uk/ (accessed 5 September 2022).
EudraCT number: Not required as non-CTIMP study.
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.
An error has occurred in processing the XML document